Hmm. The data coming out of Georgia is fantastic. Surely your cardiologist will be impressed with superior hemodynamics? Superior hemodynamics = better clinical outcomes. The data is confirming the theory of the benefits of a one piece valve.
The only point I agree with you is the company tends to be over enthusiastic about non-calcification. The links you've posted illustrates calcification does occur sometimes in Adapt tissue. However, it's all about relative competitiveness - we may not be completely 100% calcium free, but we are better than our competitors. I would be more comfortable if the company said we had superior anti calcification properties, rather than saying we have zero calcification.
AVR Price at posting:
$26.82 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)